Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans.

Figler RA, Wang G, Srinivasan S, Jung DY, Zhang Z, Pankow JS, Ravid K, Fredholm B, Hedrick CC, Rich SS, Kim JK, LaNoue KF, Linden J.

Diabetes. 2011 Feb;60(2):669-79. doi: 10.2337/db10-1070.

2.

Adenosine promotes alternative macrophage activation via A2A and A2B receptors.

Csóka B, Selmeczy Z, Koscsó B, Németh ZH, Pacher P, Murray PJ, Kepka-Lenhart D, Morris SM Jr, Gause WC, Leibovich SJ, Haskó G.

FASEB J. 2012 Jan;26(1):376-86. doi: 10.1096/fj.11-190934. Epub 2011 Sep 16.

3.

Enhanced IL-6 transcriptional response to adenosine receptor ligands in horses with lower airway inflammation.

Zhang L, Franchini M, Wehrli Eser M, Dip R.

Equine Vet J. 2012 Jan;44(1):81-7. doi: 10.1111/j.2042-3306.2010.00350.x. Epub 2011 Mar 15.

PMID:
21496101
4.

The impact of adenosine and A(2B) receptors on glucose homoeostasis.

Rüsing D, Müller CE, Verspohl EJ.

J Pharm Pharmacol. 2006 Dec;58(12):1639-45.

PMID:
17331328
5.

Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle.

Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, Friedline RH, Kurt-Jones E, Finberg R, Fischer MA, Granger EL, Norbury CC, Hauschka SD, Philbrick WM, Lee CG, Elias JA, Kim JK.

Diabetes. 2009 Nov;58(11):2525-35. doi: 10.2337/db08-1261. Epub 2009 Aug 18.

6.

Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.

Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1687-96. Epub 2007 Oct 2.

7.

EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.

Prada PO, Ropelle ER, Mourão RH, de Souza CT, Pauli JR, Cintra DE, Schenka A, Rocco SA, Rittner R, Franchini KG, Vassallo J, Velloso LA, Carvalheira JB, Saad MJ.

Diabetes. 2009 Dec;58(12):2910-9. doi: 10.2337/db08-0506. Epub 2009 Aug 20.

8.

Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation.

Ehrentraut H, Westrich JA, Eltzschig HK, Clambey ET.

PLoS One. 2012;7(2):e32416. doi: 10.1371/journal.pone.0032416. Epub 2012 Feb 28.

9.

Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance.

Wilkes JJ, Lloyd DJ, Gekakis N.

Diabetes. 2009 May;58(5):1133-43. doi: 10.2337/db08-0245. Epub 2009 Feb 10.

10.

Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines.

Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Blackburn MR, Biaggioni I, Feoktistov I.

J Pharmacol Exp Ther. 2008 Feb;324(2):694-700. Epub 2007 Oct 26.

11.

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D.

Diabetes Care. 2009 Aug;32(8):1542-6. doi: 10.2337/dc09-0684. Epub 2009 Jun 1.

12.

Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes.

Fink LN, Oberbach A, Costford SR, Chan KL, Sams A, Blüher M, Klip A.

Diabetologia. 2013 Jul;56(7):1623-8. doi: 10.1007/s00125-013-2897-x. Epub 2013 Apr 18.

PMID:
23595247
13.

No association between variation in the NR4A1 gene locus and metabolic traits in white subjects at increased risk for type 2 diabetes.

Müssig K, Machicao F, Machann J, Schick F, Claussen CD, Stefan N, Fritsche A, Häring HU, Staiger H.

BMC Med Genet. 2010 Jun 4;11:84. doi: 10.1186/1471-2350-11-84.

14.

Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.

Zinker B, Mika A, Nguyen P, Wilcox D, Ohman L, von Geldern TW, Opgenorth T, Jacobson P.

Metabolism. 2007 Mar;56(3):380-7.

PMID:
17292727
15.

Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.

Hellmann J, Tang Y, Kosuri M, Bhatnagar A, Spite M.

FASEB J. 2011 Jul;25(7):2399-407. doi: 10.1096/fj.10-178657. Epub 2011 Apr 8.

16.

Adenosine A2B receptors are highly expressed on murine type II alveolar epithelial cells.

Cagnina RE, Ramos SI, Marshall MA, Wang G, Frazier CR, Linden J.

Am J Physiol Lung Cell Mol Physiol. 2009 Sep;297(3):L467-74. doi: 10.1152/ajplung.90553.2008. Epub 2009 Jul 2.

17.

Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.

Zhao H, Yakar S, Gavrilova O, Sun H, Zhang Y, Kim H, Setser J, Jou W, LeRoith D.

Diabetes. 2004 Nov;53(11):2901-9.

18.

5'-N-ethylcarboxamide induces IL-6 expression via MAPKs and NF-kappaB activation through Akt, Ca(2+)/PKC, cAMP signaling pathways in mouse embryonic stem cells.

Kim MO, Kim MH, Lee SH, Suh HN, Lee YJ, Lee MY, Han HJ.

J Cell Physiol. 2009 Jun;219(3):752-9. doi: 10.1002/jcp.21721.

PMID:
19194991
19.

Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.

Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV.

Diabetes Care. 2004 Aug;27(8):2033-40.

PMID:
15277436
20.

Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.

Kreckler LM, Wan TC, Ge ZD, Auchampach JA.

J Pharmacol Exp Ther. 2006 Apr;317(1):172-80. Epub 2005 Dec 9.

Items per page

Supplemental Content

Write to the Help Desk